Eric Mishkin
17Patents
4h-index
21Co-inventors
56Inventor score
Filing activity: Feb 10, 1999 → Nov 4, 2011
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6488936B1 | Immunogenic composition of interleukin-12 (IL-12), alum, herpes simplex viral (HSV) antigen, and method thereof | Chemistry; Metallurgy | 26 | Expired |
| US6867000B2 | Method of enhancing immune responses to herpes | Chemistry; Metallurgy | 10 | Expired |
| US7785806B2 | Method for determining the immunogenicity of an antigen | Chemistry; Metallurgy | 9 | Active |
| US7709256B2 | Disease model incorporation into an artificial immune system (AIS) | Physics | 4 | Active |
| US8071373B2 | Co-culture lymphoid tissue equivalent (LTE) for an artificial immune system (AIS) | Chemistry; Metallurgy | 4 | Active |
| US8003385B2 | In vitro germinal centers | Chemistry; Metallurgy | 4 | Active |
| US8080416B2 | Method for determining the immunogenicity of an antigen | Chemistry; Metallurgy | 4 | Active |
| US8062889B2 | Methods of evaluating a test agent in a diseased cell model | Physics | 3 | Active |
| US7709257B2 | Models for vaccine assessment | Human Necessities | 3 | Active |
| US7771999B2 | Disease model incorporation into an artificial immune system (AIS) | Physics | 3 | Active |
| US8003387B2 | In vitro germinal centers | Chemistry; Metallurgy | 3 | Active |
| US8298824B2 | Methods of evaluating a test agent in a diseased cell model | Chemistry; Metallurgy | 3 | Active |
| US8669105B2 | Methods for assaying responses to vaccines | Chemistry; Metallurgy | 3 | Active |
| US8119403B2 | Disease model incorporation into an artificial immune system (AIS) | Physics | 2 | Active |
| US8247226B2 | Methods of evaluating an immune response to an antigen | Chemistry; Metallurgy | 2 | Active |
| US8962319B2 | Methods for testing an immune response using cultures of T cells, B cells, dendritic cells and follicular dendritic cells | Chemistry; Metallurgy | 1 | Active |
| US8697371B2 | Methods for testing an immune response using cultures of T cells, B cells and dendritic cells | Chemistry; Metallurgy | 1 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.